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Abstract
Background: Genome-wide methylation of cytosine can be modulated in the presence of TET and thymine DNA
glycosylase (TDG) enzymes. TET is able to oxidise 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC),
5-formylcytosine (5fC) and 5-carboxylcytosine (5caC). TDG can excise the oxidative products 5fC and 5caC, initiating
base excision repair. These modified bases are stable and detectable in the genome, suggesting that they could have
epigenetic functions in their own right. However, functional investigation of the genome-wide distribution of 5fC has
been restricted to cell culture-based systems, while its in vivo profile remains unknown.
Results: Here, we describe the first analysis of the in vivo genome-wide profile of 5fC across a range of tissues from
both wild-type and Tdg-deficient E11.5 mouse embryos. Changes in the formylation profile of cytosine upon depletion
of TDG suggest TET/TDG-mediated active demethylation occurs preferentially at intron-exon boundaries and
reveals a major role for TDG in shaping 5fC distribution at CpG islands. Moreover, we find that active enhancer
regions specifically exhibit high levels of 5fC, resulting in characteristic tissue-diagnostic patterns, which suggest
a role in embryonic development.
Conclusions: The tissue-specific distribution of 5fC can be regulated by the collective contribution of TET-mediated
oxidation and excision by TDG. The in vivo profile of 5fC during embryonic development resembles that of embryonic
stem cells, sharing key features including enrichment of 5fC in enhancer and intragenic regions. Additionally, by
investigating mouse embryo 5fC profiles in a tissue-specific manner, we identify targeted enrichment at active
enhancers involved in tissue development.
Background
Active DNA demethylation in mammals can be
achieved via iterative oxidation of 5-methylcytosine
(5mC) by one or more of the TET enzymes to generate 5-
hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC)
and 5-carboxylcytosine (5caC) [1–5]. 5fC and 5caC are
recognised and excised by the thymine DNA glycosy-
lase (TDG) enzyme, initiating base excision repair
(BER). Alternatively, 5fC may be lost passively during
DNA replication [5, 6]. Following the initial identifi-
cation of 5fC as an oxidative product of 5mC, 5fC
has been detected in a variety of tissues and cell sys-
tems, albeit at relatively low levels compared to 5mC
and 5hmC [4, 7]. Recently we demonstrated that 5fC
is not only detectable but also stable in vivo [8], lend-
ing credence to a biological role for 5fC beyond that
of a demethylation intermediate. Indeed, several pro-
teins have been found to specifically bind 5fC in
mouse embryonic stem cells (mESCs) and neural pre-
cursor cells (NPCs) with putative roles in transcrip-
tion, chromatin regulation and DNA repair [9, 10].
The mechanisms by which 5fC affects these processes
are not known, but it has recently been proposed that
changes in the physical properties of the DNA
double-stranded helix may be involved [11].
In the past three years, a number of different methods
have been described for the mapping of 5fC in the genome
of mESCs. These methods fall broadly into two categories:
(1) affinity enrichment methods relying on antibody or
chemical pull-downs [12–14]; and (2) base-resolution
methods based on modifications to the classical bisulphite
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sequencing (BS-seq) technique [13, 15–17]. Recently two
bisulphite-free base-resolution methods have been de-
scribed that employ either the change in base-pairing
properties (C to T) upon chemical modification [18] or
the use of a specific restriction enzyme followed by an
enrichment step [19]. Despite the methodological dif-
ferences between these techniques, a consistent picture
of the distribution of 5fC in mESCs is emerging. 5fC is
enriched at enhancers, repetitive elements and exons,
but how this relates to its distribution in tissues of a
whole organism is currently unexplored. Considering
the dynamic nature of the modification and its enrich-
ment at regulatory regions, this becomes extremely
relevant especially in the context of development,
where epigenetic modifications are subject to changes.
Here we present the first in vivo genome-wide profile
of 5fC, in tissues of the early mouse embryo. In particu-
lar, we describe the distribution of 5fC in the hindbrain,
heart, liver and carcass of embryonic day (E) 11.5 wild-
type (WT) and Tdg null embryos. The use of Tdg null
embryos enables the identification of sites marked by
active demethylation driven by TET/TDG activity in
these tissues, highlighting a potential role for 5fC in tis-
sue development and differentiation.
Results and discussion
Genomic levels of 5fC are heterogeneous in
mid-gestation staged embryos
We quantified genomic levels of 5fC from DNA ex-
tracted from whole embryos at various developmental
stages between E9.5 and E12.5 by liquid chromatog-
raphy–mass spectrometry (LC/MS) (Fig. 1a). We found
that in mid-gestational embryos, 5fC is present at levels
comparable to mouse ES cells, reaching a maximum at
E11.5–E12.5. Mice lacking the TDG enzyme show sub-
stantially higher levels of 5fC (approximately a sevenfold
increase) in accordance with its ability to excise 5fC
(Additional file 1: Figure S1A) [6]. As previously re-
ported [20, 21], Tdg null mice displayed embryonic
lethality after E11.5 with a distinct phenotype charac-
terised by haemorrhaging. We therefore decided to re-
strict our focus to E11.5 embryos for further analysis.
We previously quantified genomic 5fC levels in dissected
tissues from WT E11.5 mouse embryos by LC/MS [8].
Quantification of 5fC levels in the corresponding tissues
dissected from Tdg null (TDG null) embryos (Fig. 1b
and Additional file 1: Figure S1B) showed that levels of
5fC in the absence of Tdg are heterogeneous. Thus, the
highest levels were detected in the carcass and in the
hindbrain, where 5fC was approximately twofold higher
than the concentration found in the liver, the tissue with
the lowest 5fC levels in both WT and Tdg null embryos.
Notably, this heterogeneity shows no clear correlation with
the expression levels of TET and TDG enzymes measured
by qPCR in WT tissues (Additional file 1: Figure S1C).
Genome-wide profiling of 5fC with a traceless
chemical probe
In order to better understand the biological role of 5fC
during embryonic development we generated genome-
wide profiles for 5fC in dissected tissues from E11.5
WT and Tdg null embryos. To this end, we developed
an optimised protocol based on a previously reported
5fC-pull-down method [12], additionally employing a
cleavable aldehyde-reactive biotinylation probe as previ-
ously described [22] (Additional file 1: Figure S2A). The
hydroxylamine moiety exploits the unique reactivity of
5fC among the other DNA bases to install a biotin tag,
enabling subsequent enrichment with streptavidin
coated magnetic beads. The presence of a chemical
cleavage site (Additional file 1: Figure S2B) enables re-
moval of the biotin tag following enrichment, which al-
leviates PCR biases introduced by polymerase stalling
at modified sites [22]. This new probe and methodology
A B
Fig. 1 Genomic 5fC is heterogeneous in early embryos. a LC/MS quantification of genomic 5fC levels in mid-gestation embryos. Displayed is
the average of at least three biological replicates with standard deviation. Results are expressed as ppm (part per million over total of cytosines).
b LC/MS quantification of genomic 5fC levels in dissected tissues from WT (brown) and Tdg knockout (light blue) E11.5 embryos. Displayed is the
average of three biological replicates with standard deviation. Results are expressed as ppm (part per million over total of cytosines)
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resulted in substantially increased enrichment efficien-
cies over 30-fold higher than the previously reported
method. Through simultaneously obtaining an en-
hanced signal/noise ratio and increasing resolution, we
were able to perform sensitive and robust profiling of
5fC from relatively small amounts of embryonic-tissue-
derived genomic DNA (Additional file 1: Figure S2C).
We used this capture method to systematically perform
genome-wide profiling of 5fC in the hindbrain, heart,
liver and carcass of E11.5 embryos. At least two bio-
logical replicates were performed for each tissue and
WT and Tdg null samples were paired from the same
litter to account for litter-induced variability. A full list
of replicates is available in Additional file 1: Figure
S3A. In accordance with the data obtained by LC/MS,
Tdg null embryos show substantially higher levels of
5fC in all tissues analysed, reflected in the higher signal
and increased number of 5fC peaks in all Tdg null sam-
ples compared to their WT counterparts. Biological
replicates for the same tissues from different embryos
showed an extremely high degree of similarity, suggest-
ing a tight regulation of TET-driven formation and
TDG-mediated excision of 5fC during development.
Unbiased hierarchical clustering of all individual repli-
cates accurately separates all samples derived from
WT and Tdg null embryos, while simultaneously
pairing replicates from the same tissues (Additional
file 1: Figure S3B). One replicate for the Tdg null liver
was of poor quality and therefore was excluded from
the following analyses.
We then investigated how 5fC was distributed among
functional features within the genome. To this end, 5fC
peaks were initially called independently in each pull-
down and enrichment of peaks over genomic features
was calculated using the Genomic Association Tester
(GAT) [23]. 5fC peaks were found to be most enriched
in exons, 5′ UTRs and 3′ UTRs, while showing lesser
enrichment in introns and gene bodies. Moreover, 5fC
was depleted in the intergenic regions of all tissues ana-
lysed (Fig. 2a, b and Additional file 1: Figure S4). Al-
though higher levels of 5fC in Tdg KO tissues result in a
higher number of 5fC peaks called, the distribution of
5fC peaks over most genomic features was remarkably
similar between WT and knockout samples, suggesting
that in these regions TDG controls the level of 5fC with-
out changing its pattern (Fig. 2a, b and Additional file 1:
Figure S4). The only exception to this pattern was found
in CpG islands (CGIs), where 5fC peaks were enriched
in all WT tissues (with the exception of the carcass), but
depleted in the same tissues from embryos lacking Tdg.
It is therefore possible that TDG may be required for
TET-mediated oxidation at CpG islands, as suggested by
the physical interaction between TET1 and TDG [24], or
that excision of 5fC by TDG is less efficient at these
sites. Looking at the distribution across CGIs in more
detail, we observed that in Tdg null embryos 5fC is ab-
sent from CGIs but enriched at flanking regions, often
referred to as ‘CGI shores’ (Fig. 2c, d and Additional file
1: Figure S5). This clearly indicates a distinctive role for
TDG in shaping 5fC distribution over CpG islands that
is conserved across all embryonic tissues. This finding is
particularly relevant since aberrant methylation of CGIs
has been found in Tdg null mice and was suggested as a
possible cause of the lethal phenotype [20, 21]. Misregu-
lation of 5fC may be fundamentally involved in the aber-
rant methylation described in Tdg null embryos, which
was previously undetectable owing to the limitation of
the methylation analysis technique employed—bisulphite
sequencing—to distinguish 5fC from cytosine [20, 21].
Finally, we observed a substantial enrichment for 5fC
over exon/intron boundaries in both WT and knockout
tissues (Fig. 2e, f and Additional file 1: Figure S6). This
has also been observed for 5hmC and 5fC in embryonic
stem cells and suggests a role for oxidised cytosine de-
rivatives in regulating splicing [14, 25]. The presence of
5fC at these sites is particularly interesting, as 5fC has
been found to reduce the rate and the fidelity of tran-
scription by RNA polymerase II [26].
5fC is enriched at active enhancers in the mouse embryo
It has been reported that the genomic distribution of
5fC in mESCs shows a significant enrichment at distal
regulatory regions, mostly enhancers with high levels of
mono-methylation of lysine 4 on histone H3 (H3K4me1)
but low or absent acetylation of lysine 27 (H3K27ac)
[13]. As they are marked by the active H3K4me1, but
are still in a repressed deacetylated state, these en-
hancers are often referred to as ‘poised’. In order to in-
vestigate the distribution of 5fC in relation to functional
enhancers in vivo, we analysed the 5fC distribution in
E11.5 tissues in relation to available datasets for known
histone marks generated in mouse embryos by the
ENCODE consortium [27] (Additional file 2: Table S1).
We found that in all tissues analysed 5fC was indeed
enriched over distal regulatory regions marked by
H3K4me1. The screenshot in Fig. 3a taken from the gen-
ome browser shows an example of this striking associ-
ation. However, in contrast to mESCs, 5fC in embryonic
tissues is predominantly enriched over ‘active’ en-
hancers marked by H3K4me1 and H3K27ac (Fig. 3b
and Additional file 1: Figure S7). We found this to be
true in all tissues analysed, regardless of the presence or
absence of TDG (although 5fC levels are higher in Tdg null
embryos, relative peak enrichment is not). Notably, 5fC
displays a relatively small enrichment over regions marked
by tri-methylation of histone H3 lysine 4 (H3K4me3), a
modification associated with promoter regions of active
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genes and previously reported to show a positive correl-
ation with 5fC in mESCs (Fig. 3b) [12, 28].
We next asked whether 5fC enrichment was specific
for regions marked by activating histone modifications.
To this end, we analysed the distribution of 5fC peaks in
the hindbrain at regions marked by tri-methylation of
histone H3 lysine 36 (H3K36me3), which normally labels
transcriptional elongation and hence gene bodies, or by
tri-methylation of lysine 27 (H3K27me3), a repressive
mark deposited by the PRC2 complex. Notably, 5fC
shows very little enrichment over these regions (Fig. 3c).
Taken together, these data show a strong and specific
enrichment of 5fC at active enhancer regions during em-
bryonic development. This constitutes a significant dif-
ference in the profile of 5fC between mESCs and
embryonic tissues and could reflect a different need for
dynamic regulation in developing embryos compared to










Fig. 2 Genome-wide profiling of 5fC in vivo. a, b Enrichment of 5fC peaks over functional genomic features in E11.5 hindbrain and heart, respectively.
Log2 fold enrichment was calculated for each replicate individually using 10,000 randomisations in a simulation procedure implemented with the GAT
[21]. Plotted is the average enrichment with standard deviation. c, d Trend plot showing 5fC profile over CpG islands (+/− 5 kb) in the hindbrain and
heart, respectively. e, f Trend plot showing 5fC profile over exon/intron boundaries (+/− 5 kb) in the hindbrain and heart, respectively








Fig. 3 5fC is enriched at active enhancers in vivo. a Screenshot of a genomic region on chromosome 2 exemplifying the striking overlap of the 5fC signal with
regions marked by H3K4me1 (orange boxes) and H3K27ac (purple boxes), as calculated in [27]. b Fold enrichment of 5fC peaks in hindbrain and heart from WT
and Tdg null embryos over regions marked by H3K4me1, H3K4me3 and H3K27ac in the brain and heart of E14.5 embryos, respectively. Log2 fold enrichment was
calculated for each replicate individually using 10,000 randomisations in a simulation procedure implemented with the GAT. Plotted is the average enrichment
with standard deviation. c Comparison of 5fC peak enrichment in the hindbrain in regions marked by different histone modifications in the E14.5 mouse brain
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Tissue-specific cytosine formylation at developmental
enhancers
We next investigated whether the strong enrichment de-
tected at active enhancers was regulated in a tissue-
specific fashion. To answer this question, we analysed
5fC enrichment in heart-specific, hindbrain-specific and
liver-specific enhancers, obtained from the ENCODE
database (Additional file 2: Table S1), in the various tis-
sues. We found that in hindbrain tissues from both WT
and Tdg null embryos, 5fC was considerably enriched at
brain-specific enhancers, compared to heart-specific and
liver-specific ones. Similarly, heart-specific enhancers
were specifically enriched in the heart samples. (Fig. 4a).
These findings strongly indicate not only that there is a
dynamic regulation of 5fC at the level of enhancers, but
also that this complex mechanism is specifically focused
at tissue-specific developmental enhancers. In line with
this observation, TET-mediated active demethylation of
developmental enhancers has been recently shown to be a
conserved mechanism in vertebrate embryogenesis [29].
Finally, we investigated the relationship between
tissue-specific 5fC formation and gene function. To this
end, we subdivided 5fC peaks in the individual tissues
from Tdg null embryos into shared and tissue-specific
peaks. Notably, heart-specific 5fC peaks were enriched
in the proximity of genes involved in heart develop-
ment, whereas hindbrain-specific peaks were enriched
proximal to genes involved in neuron development
(Fig. 4b and example in Additional file 1: Figure S8).
Interestingly we could not find a similar enrichment for
liver-specific 5fC peaks, which may be due to the mixed
endoderm/mesoderm lineage of this tissue [30]. Taken
together, these results clearly indicate the presence of a
tissue-specific role for 5fC formation at the level of
genes involved in the development of the cognate
tissues.
Conclusions
We have generated the first in vivo genome-wide profile
for 5fC in tissues obtained from WT and Tdg null E11.5
mouse embryos; namely from dissected heart, hindbrain
and liver tissues and the carcass. While showing an over-
all similar profile to the ones reported in mESCs, with
enrichment at enhancers and exons, we also find that
5fC is specifically enriched at active enhancers in the de-
veloping embryo. Moreover, we report clear tissue speci-
ficity behind the distribution of 5fC in developmentally
related enhancers. This highlights a complex regulation
of 5fC, balancing of TET oxidation and TDG excision,
and thus suggesting a key role for dynamic demethyla-
tion at those sites. The relationship between this process
and the striking phenotype displayed by Tdg-deficient
embryos warrants future investigation.
Methods
Knockout mouse and tissue dissection
Tdg null mice were described in [21]. These mice contain
a deletion of the coding sequence for the catalytic domain
of TDG, which is replaced by a neomycin-resistant cas-
sette. Genotyping was carried out using DNA isolated
from the yolk sac as template with the following primers:
TDG KO/WT forward: 5′-
GGGCAGCAAGGATCTGTCTA-3′
TDG KO/WT reverse: 5′-
GCCAGTTCCTCTGACACTTAGC-3′
Mice were maintained as heterozygotes and intercrossed
to generate homozygous knockout embryos for analysis.
Tissues were collected from timed matings with the day of
the copulation plug as E0.5. Embryos were dissected into
hindbrain, heart, liver and carcass.
DNA and RNA extraction
Embryonic tissues were lysed in RLT plus buffer (Qiagen),
homogenised via centrifugation through a QIAshreddred
column (Qiagen) at full speed for 2 min in a microcen-
trifuge. DNA and RNA were isolated using AllPrep
DNA/RNA kit (Qiagen) following the manufacturer’s
instructions.
Mass spectrometry of DNA
A total of 100–300 ng of genomic DNA was treated with
5 U of DNA Degradase Plus (Zymo Research) for 3 h
and analysed on a nanoHPLC combined with a Q Exac-
tive mass spectrometer, as previously described [31].
Pull-down method
Genomic DNA (500 ng in 10 mM Tris–HCl pH 8,
1 mM EDTA) was sonicated to an average of 250 bp
with the Covaris M220 Focused-ultrasonicator. Synthetic
spike-in controls were added after sonication to monitor
the enrichment efficiency (full details on the spike-in oli-
gos and conditions used are in Additional file 3). The
fragmented DNA was incubated with a cleavable alde-
hyde reactive biotinylation probe [22] (400 μM), p-anisi-
dine (100 mM) and NH4OAc (40 mM, adjusted to pH 5
with AcOH) in a final volume of 100 μL at 37 °C with a
65 °C heated lid for 24 h. The DNA was purified on
silica-based spin columns (GeneJET PCR Purification
Kit), with the inclusion of an additional wash step, be-
fore standard library preparation.
Streptavidin paramagnetic particles (50 μL, Promega
Magnesphere PMPs) were washed with 1× binding buf-
fer (5 mM Tris-HCl pH 7.2, 0.5 mM EDTA, 1 M NaCl,
0.05 % Tween-20) (four times 500 μL) and resuspended
in 2× binding buffer (50 μL). The washed beads (50 μL),
dIdC (2 μL of 1 μg/μL), spike-in control sequences
Iurlaro et al. Genome Biology  (2016) 17:141 Page 6 of 9
AB
Fig. 4 (See legend on next page.)
Iurlaro et al. Genome Biology  (2016) 17:141 Page 7 of 9
(1 pg positive control; 10 pg negative control), DNA
library and water were combined in a 1.5 mL low binding
tube (Eppendorf DNA LoBind) to give 100 μL. The mix-
ture was incubated at room temperature for 20 min, be-
fore the tube was placed on a magnetic rack and left for
5 min while the magnetic beads formed a pellet. Once the
solution was clear the supernatant was discarded, and
400 μL 1× binding buffer was added to the tube. The
beads were washed by rapidly rotating the tube 180° and
allowing the beads to recollect against the magnet; this
washing procedure was repeated four times. The beads
were resuspended in 400 μL 1× binding buffer with vor-
texing and transferred to a new low binding tube before
the washing procedure was repeated another four times.
A final tube transfer and washing cycle was performed,
giving a total of two tube changes and 12 washes. A final
wash with Tris–HCl (10 mM) was performed, with the
beads remaining on the magnet at all times due to poor
pellet formation in this buffer.
The DNA was eluted from the beads by chemical
cleavage of the probe with 100 μL of tris(2-carbox-
yethyl)phosphine (100 mM) and Tris–HCl (200 mM)
shaken at 65 °C for 15 min. NaOAc (40 μL of 5 M,
pH 5), ethanol (1 mL) and water (100 μL) were added to
the isolated supernatant, and the mixture held at −80 °C
for 45 min. The precipitated DNA was pelleted by cen-
trifugation at 16,000 rcf for 45 min, washed with 70 %
EtOH and centrifuged again at 16,000 rcf for 30 min.
The pellet was air dried and dissolved in water (20 μL).
At this point the enrichment efficiency was examined
by qPCR of the control sequences spiked in before
pull-down. One microliter of enriched DNA was di-
luted tenfold, from which 1 μL aliquots were amplified
with primer sets for the positive and negative controls.
Comparison to a non-enriched input gave the enrich-
ment factor (Additional file 1: Figure S9 and Additional
file 3). Although the enrichment was extremely high
(~54,000-fold), there will be a proportion of false-positive
regions arising from the excess of non-formylated DNA in
genomic context.
Library preparation and sequencing
Sequencing libraries were generated using the NEBNext
library preparation modules. Fourteen cycles of PCR amp-
lification were performed with the Illumina PCR Master
Mix and PCR Primer Cocktail. Prior to sequencing, librar-
ies were quantified by qPCR (KAPA Biosystems) and their
fragment size profile analysed by TapeStation (Agilent).
Sequencing was performed on an Illumina Nextseq 500,
run in paired-end mode with 100 read cycles.
Bioinformatic analysis
Raw sequencing files and peak files can be found in the
GEO under accession number GSE77447. Data were
adapter and quality trimmed using trim_galore v0.4.1
(bioinformatics.babraham.ac.uk/projects/trim_galore/)
using default settings. Trimmed sequencing reads were
aligned to mouse genome assembly NCBIM37 (mm9)
using Bowtie2 v2.2.6 using default parameters [32] and
was converted to BAM format using samtools v0.1.18
[33]. Peaks were called in the SeqMonk software (bioin-
formatics.babraham.ac.uk/projects/seqmonk/) using the
MACS peak caller [34], with a p value cutoff of 1 × 10−5
and a fragment size of 200 bp. Data manipulations were
facilitated by BEDTools [35] and data analysis was per-
formed in Seqmonk or in R version 3.1.2 [36].
Gene Ontology
Functional annotation enrichment analyses were per-
formed using the Database for Annotation, Visualization
and Integrated Discovery (DAVID) v6.7 [37].
Additional files
Additional file 1: Supplementary figures and supplementary figure
legends. (PDF 841 kb)
Additional file 2: Table S1. ENCODE datasets analysed. (PDF 53 kb)
Additional file 3: Full details on spike-in control oligos. (PDF 226 kb)
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